Rynek zdrowia - Strategie neuroprotekcji w urazach rdzenia kręgowego

Gorące tematy

Drukuj
Komentarze

Strategie neuroprotekcji w urazach rdzenia kręgowego

Piotr Tederko, Marek Krasuski, Jerzy Kiwerski, Izabella Nyka, Dariusz Białoszewski
26-10-2009 10:44

15. Massey JM, Amps J, Viapiano MS, Matthews RT, Wagoner MR, Whitaker CM i wsp. Increased chondroitin sulfate proteoglycan expression in denervated brainstem targets following spinal cord injury creates a barrier to axonal regeneration overcome by chondroitinase ABC and neurotrophin-3. Exp Neurol 2008;209(2):426-45.

16. Nakamura M, Okada S, Toyama Y, Okano H. Role of IL-6 in spinal cord injury in a mouse model. Clin Rev Allergy Immunol. 2005;28(3):197-204.

17. Hurlbert RJ. Strategies of medical intervention in the management of acute spinal cord injury. Spine 2006;31(11 Suppl):S16-21

18. Tsutsumi S, Ueta T, Shiba K, Yamamoto S, Takagishi K. Effects of the Second National Acute Spinal Cord Injury Study of high-dose methylprednisolone therapy on acute cervical spinal cord injury-results in spinal injuries center. Spine 2006;31(26):2992-6.

19. Hawryluk GW, Rowland J, Kwon BK, Fehlings MG. Protection and repair of the injured spinal cord: a review of completed, ongoing, and planned clinical trials for acute spinal cord injury. Neurosurg Focus 2008;25(5):E14.

20. Hugenholtz H. Methylprednisolone for acute spinal cord injury: not a standard of care. CMAJ 2003;168:1145-6.

21. Hall ED, Sprinter JE. Neuroprotection and acute spinal cord injury: a reappraisal. NeuroRx 2004;1:80-100.

22. Bracken MB, Shephard MJ, Holford TR, Leo-Summers L, Aldrich EF, Fazl M i wsp. Administration of methylprednisolone for 24 to 48 hours or tirilazad mesylate for 48 hours in the treatment of acute spinal cord injury: 1-year follow up. Results of the third National Acute Spinal Cord Injury randomized controlled trial. National Acute Spinal Cord Injury Study. JAMA 1997;277:1597-604.

23. Chinnock P, Roberts I. Gangliosides for acute spinal cord injury. Cochrane Database Syst Rev 2005;(2):CD004444.

24. Steeves J, Fawcett J, Tuszynski M. Report of International Clinical Trials Workshop on Spinal Cord Injury February 20-21, 2004, Vancouver, Canada. Spinal Cord 2004;42:591-7.

25. Stirling DP, Koochesfahani KM, Steeves JD, Tetzlaff W. Minocycline as a neuroprotective agent. Neuroscientist 2005;11(4):308-22.

26. Ruitenberg MJ, Levison DB, Lee SV, Verhaagen J, Harvey AR, Plant GW. NT-3 expression from engineered olfactory ensheathing glia promotes spinal sparing and regeneration. Brain 2005;128(Pt 4):839-53.

27. Kaas JH, Qi HX, Burish MJ, Gharbawie OA, Onifer SM, Massey JM. Cortical and subcortical plasticity in the brains of humans, primates, and rats after damage to sensory afferents in the dorsal columns of the spinal cord. Exp Neurol 2008; 209(2):407-16.